Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian,

Slides:

Advertisements

Similar presentations

Updates on Breast Diseases: What clinicians need to know from pathologists Preah Bat Norodom Sihanouk Hopsital, 22 April 2009 Monirath Hav, MD, Ph.D. fellow.

Advertisements

TOP2A IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN UNSELECTED BREAST CANCER Amit Pancholi Molecular Profiling of Breast Cancer: Predictive Markers of Long.

Mammary ductal carcinoma

Baptist Health System General Surgery Residency Program

Slide Seminar Sami Shousha, MD, FRCPath Department of Histopathology, Charing Cross Hospital & Imperial College, London Amman, November 2013.

Breast Cancer Tumor Board Chair Harold Burstein, MD, PhD Faculty Jennifer Bellon, MD Mehra Golshan, MD.

Microscopically Yours: A Glimpse at our Cells, in Sickness and in Health Nina C. Zanetti Siena College Department of Biology.

What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)

A program of the UAMS College of Pharmacy

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

AJCC TNM Staging 7th Edition Breast Case #3

Breast Imaging Made Brief and Simple

The All Breast Cancer Report was published in October breastscreen/research.html#breast- cancer-report.

Genetic and Molecular Epidemiology

Ductal Carcinoma in situ

Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.

Microwave Thermography

Breast Cancer Clinical Cases Daniel A. Nikcevich, MD, PhD SMDC Cancer Center April 20, 2009.

BREAST CANCER OVERVIEW Polly Stephens, M.D.. BREAST ANATOMY.

Suggested guidelines for appropriate patient selection for patients undergoing Accelerated Partial Breast Irradiation at DMC. Tonya Echols Cole, MD.

AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.

Comparing the Positive Effect of Vitamin E and Flouxetine in the Treatment of Hot Flashes in Breast Cancer Patients. Comparing the Positive Effect of.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.

A Phase II Study to Evaluate the Safety and Toxicity of Sparing Radiation to the Pathologic N0 Side of the Neck in Squamous Cell.

The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.

NYU Medical Grand Rounds Clinical Vignette Daniel P. Eiras, MD, MPH PGY2 December 1, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

1 CAP Audio Conference on the CMS 2009 Physician Quality Reporting Initiative Jonathan Myles, MD, FCAP College of American Pathologists December 17, 2008.

11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,

Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.

Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:

Neoadjuvant SystemicTreatment Strategies for Breast Cancer Donald W. Northfelt, MD, FACP Professor of Medicine Mayo Clinic College of Medicine Associate.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Understanding Cancer and Related Topics

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

Senior Statistician Per-Henrik Zahl, MA MD PhD

Radiotherapy Protocols Bristol protocol version 12.

Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.

Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.

Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in

From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.

Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.

Radiological-histological size correlation in triple-negative breast cancer (TNBC) Abstract # 8254 C Thibault 1, M Gosset 2, F Chamming’s 3, M-A Lefrere-Belda.

CLINICAL ASPECT OF GRADING AND STAGING Hanggoro Tri Rinonce, MD, PhD Department of Anatomical Pathology Faculty of Medicine, Gadjah Mada University.

Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.

Number of brain metastasis

Nurdianah HF, Nizuwan A, Muhamad Yusri M

Table 2. Association between histology grade, lymph node status,

RADIOLOGICAL AND HISTOPATHOLOGICAL CHARACTERISTIC FEATURES OF BREAST CANCER PATIENTS IN HOSPITAL SERDANG Lim SN.1, Nuratika B.1, Suraini M.S.2, Norafida.

W. Scott Campbell, MBA, PhD University of Nebraska Medical Center

Marcelo Calil Instituto Brasileiro de Controle do Câncer

W. Scott Campbell, MBA, PhD University of Nebraska Medical Center

S1207: Phase III randomized, placebo-controlled trial adding 1 year of everolimus to adjuvant endocrine therapy for patients with high-risk, HR+, HER2-

Table (1):Relation between lymph node and molecular subtypes.

Prof. Shaila Anwar Professor Obs & Gynae

But how to treat those with positive SLNB? Results and Discussion

Thanh Nhan Hospital MALE BREAST CANCER: CASE REPORT

Predict “invasive component” within ductal carcinoma in situ – the breast MRI features and clinicopathologic factors ? Hung-Wen Lai, MD, PhD1,4, Dar-Ren.

徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2

Metastatic Breast cancer

Treatment Overview: The Multidisciplinary Team

Handling and Evaluation of Breast Cancer Biopsy

Stamatia Destounis, MD, FACR, FSBI, FAIUM

Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.

Presentation transcript:

Epidemiological study on INVASIVE BREAST CANCER treated at Hotel Dieu de France Hospital University of Saint-Joseph Faculty of Medicine Gerard Abadjian, M.D. Assistant Professor of Pathology Head of department of Pathology Hotel Dieu de France Hospital Maguy Abou Hamad, M.D. Department of Pathology Hotel Dieu de France Hospital Clement El Khoury, M.D. First year Medicine Residency Hotel Dieu de France Hospital Retrospective study on 434 cases ( )

Plan of the Study ● Descriptive: Age, tumor size, type & histological grade, number of positive lymph nodes. ● Analytical: Modification of these variables threw time. Relations between variables. ● Comparative: Cases between July 1991 & June 1999.

Material & Methodes Data collection -> Pathology registers Exclusion criterias: -> Male patients -> Neoadjuvant therapy -> Biopsy before surjery. Histological grading -> Scarff-Bloom- Richardson (SBR) Statistical analysis -> SPSS 11.0®

Results Average age -> 53.6 yrs, no variation linked to time Tumor size -> constant 3.2 cm Infiltrating ductal carcinoma the most frequent, Grade III (SBR) Number of postive lymph nodes + histological grading increase along with tumor size.

Age Average age -> 53.6 yrs Most frequent age section -> yrs Age -/-> Time

Tumor size variation between 1991 & Study Current study

Tumor size ≤ 1 cm

Carcinoma in situ

Variation of positive lymph nodes from 1991 till 2006 Number of positive lymph nodes 2000 studyCurrent study

Conclusion Stability of tumor size over the years including ≤ 1 cm => uneffective screening strategies + poor educational programs. Solutions: -> Well organized national screening programs. -> Extensive clinical & pathological studies. -> Educational & advertising campaigns. -> Initiation of all women for breast self- examination test.

Thank you